BOSTON--(BUSINESS WIRE)--Aug 22, 2024-- PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating diseases, today announced that Michele Holcomb, PhD, will join its board of directors as an independent non-executive director. Dr. Holcomb’s appointment will take effect as of September 23, 2024.
She brings more than 30 years of expertise leading global healthcare companies through strategic inflection points and preparing innovative programs and portfolios for growth. This press release features multimedia. View the full release here: https://www.
businesswire.com/news/home/20240821665245/en/ PureTech Appoints Michele Holcomb, PhD, to Board of Directors (Photo: Business Wire) “As PureTech enters its next phase of growth focused on innovating and progressing major advances for patients, Dr. Holcomb brings a wealth of experience to our strategy that’s built among highly visible healthcare organizations,” said Bharatt Chowrira, PhD, JD, Chief Executive Officer of PureTech.
“She has a proven track record of leading transformational growth initiatives and driving organizational progress that will complement our board’s exceptional leadership, and we will greatly benefit from Dr. Holcomb’s broad biopharma experience as we deliver on our commitment to bring highly innovative and differentiated new medicines to patients and build value for all of our sha.